[(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium
C43H60ClN10O4+ — CID 176575750
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium
[(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium (PubChem CID 176575750) has the molecular formula C43H60ClN10O4+ and a molecular weight of 816.47 g/mol. Its IUPAC name is [(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium.
Molecular Properties
| Compound Name | [(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium |
|---|---|
| PubChem CID | 176575750 |
| Molecular Formula | C43H60ClN10O4+ |
| Molecular Weight | 816.47 g/mol |
| Exact Mass | 815.45 |
| IUPAC Name | [(1S)-1-(4-chlorophenyl)-3-[4-[1-(piperazin-1-ylmethyl)-2-oxabicyclo[2.2.2]octane-4-carbonyl]piperazin-1-yl]propyl]-[1-[(2-methylpropan-2-yl)oxycarbonyl]-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[2.5]octan-2-ylidene]azanium |
| SMILES | CC(C)(C)OC(=O)N1/C(=[NH+]\[C@@H](CCN2CCN(C(=O)C34CCC(CN5CCNCC5)(CC3)OC4)CC2)c2ccc(Cl)cc2)C12CCN(c1ncnc3[nH]ccc13)CC2 |
| InChI | InChI=1S/C43H59ClN10O4/c1-40(2,3)58-39(56)54-37(43(54)14-20-52(21-15-43)36-33-8-16-46-35(33)47-30-48-36)49-34(31-4-6-32(44)7-5-31)9-19-50-24-26-53(27-25-50)38(55)41-10-12-42(13-11-41,57-29-41)28-51-22-17-45-18-23-51/h4-8,16,30,34,45H,9-15,17-29H2,1-3H3,(H,46,47,48)/p+1/b49-37-/t34-,41?,42?,54?/m0/s1 |
| InChIKey | PGTRXTMKDJZMNB-IIUHSCGPSA-O |
| XLogP | 3.19 |
| TPSA | 136.14 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 816.47 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176575750 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.